CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore patent oppositions filed by Novartis against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Jul 31, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Il-17 A/F Heterologous Polypeptides And Therapeutics Uses ThereofGENENTECHJul 24, 2019
Contact Lens With A Hydrophilic LayerOCULAR DYNAMICSJan 18, 2019
Ionic Silicone HydrogelsJOHNSON & JOHNSON VISION CAREOct 24, 2018
Macroinitiator Containing Hydrophobic SegmentJOHNSON & JOHNSON VISION CAREOct 10, 2018
Polymers And Nanogel Materials And Methods For Making And Using The SameJOHNSON & JOHNSON VISION CAREAug 1, 2018
Hydrogel Contact Lenses And Package Systems And Production Methods For SameCOOPERVISIONFeb 9, 2018

Explore Novartis's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jul 31, 2025
Patent NumberGrant DateTitleTotal Oppositions
Jan 15, 2025A Rapamycin Derivative For Treating Lung Cancer7
Oct 23, 2024New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)17
Aug 21, 2024Methods Of Treating New-Onset Plaque Type Psoriasis Using Il-17 Antagonists7
Jul 3, 2024Novel Pharmaceutical Composition7
May 1, 2024Silicone Hydrogel Lenses With Water-Rich Surfaces1
Apr 24, 2024Oral Formulations Of Deferasirox2
Apr 17, 2024Methods For Preventing Cardiovascular Events Through Proprotein Convertase Subtilisin Kexin 9 (Pcsk9) Protein Reduction5
Apr 10, 2024Use Of Il-17 Antagonists To Inhibit The Progression Of Structural Damage In Psoriatic Arthritis Patients3
Apr 3, 2024Treatment Of Cancer Using Anti-Cd19 Chimeric Antigen Receptor1
Feb 14, 2024Novel Pharmaceutical Composition4

Top competitors of Novartis

List of top competitors of Novartis based on patent oppositions.